Key Points
-
A pivotal role for the renal calcium-sensing receptor (CaSR) in the control of divalent cation excretion in a parathyroid hormone-independent manner has been identified through tissue-specific CaSR ablation and pharmacological studies
-
A functional interaction between the CaSR and Claudin-14 in the thick ascending limb permits regulation of paracellular Ca2+ reabsorption
-
The CaSR fine tunes Ca2+, Mg2+, and Pi transport in the proximal tubule by integrating multiple inputs from divalent cation concentration, osmolarity, and urine acidification
-
Calcimimetics would be expected to increase urinary Ca2+ excretion by acting on the CaSR in the parathyroid glands and the kidney
-
Calcilytics represent a novel, promising avenue for the treatment of hypercalciuria, nephrolithiasis, and nephrocalcinosis
-
The CaSR and adenylyl cyclase type 6 are co-expressed in the nephron and act to sensitize hormones to extracellular Ca2+ and counteract hormone-induced increases in cAMP
Abstract
The ability to monitor changes in the ionic composition of the extracellular environment is a crucial feature that has evolved in all living organisms. The cloning and characterization of the extracellular calcium-sensing receptor (CaSR) from the mammalian parathyroid gland in the early 1990s provided the first description of a cellular, ion-sensing mechanism. This finding demonstrated how cells can detect small, physiological variations in free ionized calcium (Ca2+) in the extracellular fluid and subsequently evoke an appropriate biological response by altering the secretion of parathyroid hormone (PTH) that acts on PTH receptors expressed in target tissues, including the kidney, intestine, and bone. Aberrant Ca2+ sensing by the parathyroid glands, as a result of altered CaSR expression or function, is associated with impaired divalent cation homeostasis. CaSR activators that mimic the effects of Ca2+ (calcimimetics) have been designed to treat hyperparathyroidism, and CaSR antagonists (calcilytics) are in development for the treatment of hypercalciuric disorders. The kidney expresses a CaSR that might directly contribute to the regulation of many aspects of renal function in a PTH-independent manner. This Review discusses the roles of the renal CaSR and the potential impact of pharmacological modulation of the CaSR on renal function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brown, E. M. et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366, 575–580 (1993).
Brown, E. M. & MacLeod, R. J. Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 81, 239–297 (2001).
Block, G. A. et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N. Engl. J. Med. 350, 1516–1525 (2004).
Bushinsky, D. A. et al. Treatment of secondary hyperparathyroidism: results of a phase 2 trial evaluating an intravenous peptide agonist of the calcium-sensing receptor. Am. J. Nephrol. 42, 379–388 (2015).
US National Library of Medicine. ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT01788046 (2015).
Letz, S. et al. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia. PLoS ONE 9, e115178 (2014).
Riccardi, D. et al. Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am. J. Physiol. 274, F611–F622 (1998).
Marx, S. J. et al. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 47, 1190–1197 (1978).
Attie, M. F. et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J. Clin. Invest. 72, 667–676 (1983).
Loupy, A. et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J. Clin. Invest. 122, 3355–3367 (2012).
Gong, Y. et al. Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J. 31, 1999–2012 (2012).
Gong, Y. & Hou, J. Claudin-14 underlies Ca++-sensing receptor-mediated Ca++ metabolism via NFAT-microRNA-based mechanisms. J. Am. Soc. Nephrol. 25, 745–760 (2014).
Gong, Y., Himmerkus, N., Plain, A., Bleich, M. & Hou, J. Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling. J. Am. Soc. Nephrol. 26, 663–676 (2015).
Riccardi, D. & Brown, E. M. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am. J. Physiol. Renal Physiol. 298, F485–F499 (2010).
Graca, J. A. Z. et al. Comparative expression of the extracellular calcium sensing receptor in mouse, rat, and human kidney. Am. J. Physiol. Renal Physiol. 310, F518–F533 (2015).
Kwak, J. O. et al. The extracellular calcium sensing receptor is expressed in mouse mesangial cells and modulates cell proliferation. Exp. Mol. Med. 37, 457–465 (2005).
Meng, K. et al. Calcium sensing receptor modulates extracellular calcium entry and proliferation via TRPC3/6 channels in cultured human mesangial cells. PLoS ONE 9, e98777 (2014).
Oh, J. et al. Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int. 80, 483–492 (2011).
Gut, N. et al. The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE−/− mice. Am. J. Physiol. Renal Physiol. 305, F277–F285 (2013).
Wang, L. et al. Gq signaling causes glomerular injury by activating TRPC6. J. Clin. Invest. 125, 1913–1926 (2015).
Churchill, P. C. Second messengers in renin secretion. Am. J. Physiol. 249, F175–F184 (1985).
Atchison, D. K., Ortiz-Capisano, M. C. & Beierwaltes, W. H. Acute activation of the calcium-sensing receptor inhibits plasma renin activity in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1020–R1026 (2010).
Grunberger, C., Obermayer, B., Klar, J., Kurtz, A. & Schweda, F. The calcium paradoxon of renin release: calcium suppresses renin exocytosis by inhibition of calcium-dependent adenylate cyclases AC5 and AC6. Circ. Res. 99, 1197–1206 (2006).
Beierwaltes, W. H. The role of calcium in the regulation of renin secretion. Am. J. Physiol. Renal Physiol. 298, F1–F11 (2010).
Murer, H., Hernando, N., Forster, I. & Biber, J. Molecular aspects in the regulation of renal inorganic phosphate reabsorption: the type IIa sodium/inorganic phosphate co-transporter as the key player. Curr. Opin. Nephrol. Hypertens. 10, 555–561 (2001).
Ba, J., Brown, D. & Friedman, P. A. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am. J. Physiol. Renal Physiol. 285, F1233–F1243 (2003).
Di Mise, A. et al. Conditionally immortalized human proximal tubular epithelial cells isolated from the urine of a healthy subject express functional calcium-sensing receptor. Am. J. Physiol. Renal Physiol. 308, F1200–F1206 (2015).
Riccardi, D. et al. Dietary phosphate and parathyroid hormone alter the expression of the calcium-sensing receptor (CaR) and the Na+-dependent Pi transporter (NaPi-2) in the rat proximal tubule. Pflugers Arch. 441, 379–387 (2000).
Bland, R., Walker, E. A., Hughes, S. V., Stewart, P. M. & Hewison, M. Constitutive expression of 25-hydroxyvitamin D3-1α-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 140, 2027–2034 (1999).
Egbuna, O. et al. The full-length calcium-sensing receptor dampens the calcemic response to 1α,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone. Am. J. Physiol. Renal Physiol. 297, F720–F728 (2009).
Capasso, G. et al. The calcium sensing receptor modulates fluid reabsorption and acid secretion in the proximal tubule. Kidney Int. 84, 277–284 (2013).
Zhang, Y. et al. In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition. Am. J. Physiol. 276, F711–F719 (1999).
Friedman, P. A. Codependence of renal calcium and sodium transport. Annu. Rev. Physiol. 60, 179–197 (1998).
Wittner, M., Mandon, B., Roinel, N., de Rouffignac, C. & Di Stefano, A. Hormonal stimulation of Ca2+ and Mg2+ transport in the cortical thick ascending limb of Henle's loop of the mouse: evidence for a change in the paracellular pathway permeability. Pflugers Arch. 423, 387–396 (1993).
Takaichi, K. & Kurokawa, K. High Ca2+ inhibits peptide hormone-dependent cAMP production specifically in thick ascending limbs of Henle. Miner. Electrolyte Metab. 12, 342–346 (1986).
de Jesus Ferreira, M. C. et al. Co-expression of a Ca2+-inhibitable adenylyl cyclase and of a Ca2+-sensing receptor in the cortical thick ascending limb cell of the rat kidney. Inhibition of hormone-dependent cAMP accumulation by extracellular Ca2+. J. Biol. Chem. 273, 15192–15202 (1998).
Kieferle, S., Fong, P., Bens, M., Vandewalle, A. & Jentsch, T. J. Two highly homologous members of the ClC chloride channel family in both rat and human kidney. Proc. Natl Acad. Sci. USA 91, 6943–6947 (1994).
Welling, P. A. & Ho, K. A comprehensive guide to the ROMK potassium channel: form and function in health and disease. Am. J. Physiol. Renal Physiol. 297, F849–F863 (2009).
Wang, W., Lu, M., Balazy, M. & Hebert, S. C. Phospholipase A2 is involved in mediating the effect of extracellular Ca2+ on apical K+ channels in rat TAL. Am. J. Physiol. 273, F421–F429 (1997).
Kong, S. et al. Stimulation of Ca2+-sensing receptor inhibits the basolateral 50-pS K channels in the thick ascending limb of rat kidney. Biochim. Biophys. Acta 1823, 273–281 (2012).
Toka, H. R., Pollak, M. R. & Houillier, P. Calcium sensing in the renal tubule. Physiology (Bethesda) 30, 317–326 (2015).
Vargas-Poussou, R. et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J. Am. Soc. Nephrol. 13, 2259–2266 (2002).
Vezzoli, G. et al. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. J. Nephrol. 19, 525–528 (2006).
Simon, D. B. et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat. Genet. 14, 152–156 (1996).
Simon, D. B. et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2Cl cotransporter NKCC2. Nat. Genet. 13, 183–188 (1996).
Dimke, H. et al. Activation of the Ca2+-sensing receptor increases renal claudin-14 expression and urinary Ca2+ excretion. Am. J. Physiol. Renal Physiol. 304, F761–F769 (2013).
Toka, H. R. et al. Deficiency of the calcium-sensing receptor in the kidney causes parathyroid hormone-independent hypocalciuria. J. Am. Soc. Nephrol. 23, 1879–1890 (2012).
Courbebaisse, M. et al. Effects of cinacalcet in renal transplant patients with hyperparathyroidism. Am. J. Nephrol. 35, 341–348 (2012).
de Groot, T. et al. Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation. J. Am. Soc. Nephrol. 20, 1693–1704 (2009).
de Groot, T., Bindels, R. J. & Hoenderop, J. G. TRPV5: an ingeniously controlled calcium channel. Kidney Int. 74, 1241–1246 (2008).
Topala, C. N. et al. Activation of the Ca2+-sensing receptor stimulates the activity of the epithelial Ca2+ channel TRPV5. Cell Calcium 45, 331–339 (2009).
Huang, C. et al. Interaction of the Ca2+-sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function. Am. J. Physiol. Renal Physiol. 292, F1073–F1081 (2007).
Yang, T. et al. Expression of PTHrP, PTH/PTHrP receptor, and Ca(2+)-sensing receptor mRNAs along the rat nephron. Am. J. Physiol. 272, F751–F758 (1997).
Renkema, K. Y. et al. The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. J. Am. Soc. Nephrol. 20, 1705–1713 (2009).
Tessitore, N. et al. Renal acidification defects in patients with recurrent calcium nephrolithiasis. Nephron 41, 325–332 (1985).
Buckalew, V. M. Jr Nephrolithiasis in renal tubular acidosis. J. Urol. 141, 731–737 (1989).
Sands, J. M. et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J. Clin. Invest. 99, 1399–1405 (1997).
Brown, E. M. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am. J. Med. 106, 238–253 (1999).
Earm, J. H. et al. Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. J. Am. Soc. Nephrol. 9, 2181–2193 (1998).
Valenti, G. et al. Urinary aquaporin 2 and calciuria correlate with the severity of enuresis in children. J. Am. Soc. Nephrol. 11, 1873–1881 (2000).
Valenti, G. et al. Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Am. J. Physiol. Renal Physiol. 283, F895–F903 (2002).
Procino, G. et al. Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int. 66, 2245–2255 (2004).
Bustamante, M. et al. Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism. J. Am. Soc. Nephrol. 19, 109–116 (2008).
Renkema, K. Y. et al. TRPV5 gene polymorphisms in renal hypercalciuria. Nephrol. Dial. Transplant. 24, 1919–1924 (2009).
Procino, G. et al. Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study. PLoS ONE 7, e33145 (2012).
Ranieri, M. et al. Negative feedback from CaSR signaling to aquaporin-2 sensitizes vasopressin to extracellular Ca2+. J. Cell Sci. 128, 2350–2360 (2015).
Tamma, G. et al. A decrease in aquaporin 2 excretion is associated with bed rest induced high calciuria. J. Transl. Med. 12, 133 (2014).
Procino, G. et al. Aquaporin 2 and apical calcium-sensing receptor: new players in polyuric disorders associated with hypercalciuria. Semin. Nephrol. 28, 297–305 (2008).
Bergsland, K. J., Coe, F. L., Gillen, D. L. & Worcester, E. M. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am. J. Physiol. Renal Physiol. 297, F1017–F1023 (2009).
Fenton, R. A. et al. Renal phosphate wasting in the absence of adenylyl cyclase 6. J. Am. Soc. Nephrol. 25, 2822–2834 (2014).
Rieg, T. et al. Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC. Am. J. Pathol. 182, 96–106 (2013).
Nearing, J. et al. Polyvalent cation receptor proteins (CaRs) are salinity sensors in fish. Proc. Natl Acad. Sci. USA 99, 9231–9236 (2002).
Ortiz-Capisano, M. C., Reddy, M., Mendez, M., Garvin, J. L. & Beierwaltes, W. H. Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP3 pathway and the ryanodine receptor. Am. J. Physiol. Renal Physiol. 304, F248–F256 (2013).
Gimenez, I. & Forbush, B. Short-term stimulation of the renal Na–K–Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J. Biol. Chem. 278, 26946–26951 (2003).
Gunaratne, R. et al. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc. Natl Acad. Sci. USA 107, 15653–15658 (2010).
Hoffert, J. D., Chou, C. L., Fenton, R. A. & Knepper, M. A. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J. Biol. Chem. 280, 13624–13630 (2005).
Rieg, T. et al. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla. J. Am. Soc. Nephrol. 21, 2059–2068 (2010).
Chabardes, D. et al. Localization of mRNAs encoding Ca2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the cAMP content. J. Biol. Chem. 271, 19264–19271 (1996).
Helies-Toussaint, C., Aarab, L., Gasc, J. M., Verbavatz, J. M. & Chabardes, D. Cellular localization of type 5 and type 6 ACs in collecting duct and regulation of cAMP synthesis. Am. J. Physiol. Renal Physiol. 279, F185–F194 (2000).
Roos, K. P., Strait, K. A., Raphael, K. L., Blount, M. A. & Kohan, D. E. Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice. Am. J. Physiol. Renal Physiol. 302, F78–F84 (2012).
Vezzoli, G., Terranegra, A. & Soldati, L. Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr. Opin. Nephrol. Hypertens. 21, 355–361 (2012).
Kelly, C., Gunn, I. R., Gaffney, D. & Devgun, M. S. Serum calcium, urine calcium and polymorphisms of the calcium sensing receptor gene. Ann. Clin. Biochem. 43, 503–506 (2006).
Bushinsky, D. A. Nephrolithiasis: site of the initial solid phase. J. Clin. Invest. 111, 602–605 (2003).
Thorleifsson, G. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat. Genet. 41, 926–930 (2009).
Hou, J. The role of claudin in hypercalciuric nephrolithiasis. Curr. Urol. Rep. 14, 5–12 (2013).
Arcidiacono, T. et al. Idiopathic calcium nephrolithiasis: a review of pathogenic mechanisms in the light of genetic studies. Am. J. Nephrol. 40, 499–506 (2014).
Lerolle, N. et al. No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol. Dial. Transplant. 16, 2317–2322 (2001).
Petrucci, M. et al. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int. 58, 38–42 (2000).
Vezzoli, G. et al. R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int. 71, 1155–1162 (2007).
Harding, B. et al. Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density. Clin. Endocrinol. (Oxf.) 65, 598–605 (2006).
Vezzoli, G. et al. Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis. J. Clin. Endocrinol. Metab. 98, 3839–3847 (2013).
Vezzoli, G. et al. Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene. J. Nephrol. 28, 67–72 (2015).
Oddsson, A. et al. Common and rare variants associated with kidney stones and biochemical traits. Nat. Commun. 6, 7975 (2015).
Fitzpatrick, L. A. et al. The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density. J. Clin. Endocrinol. Metab. 96, 2441–2449 (2011).
Kimura, S. et al. JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats. Eur. J. Pharmacol. 668, 331–336 (2011).
Acknowledgements
The authors acknowledge financial support from the Marie Curie Initial Training Network for the project “Multifaceted CaSR” (to D.R.) and Telethon funding for the project “Aquaporin-2 and calcium-sensing receptor: new players regulating water handling in familial hypercalciuria” (to G.V.). The authors are grateful to Drs Edward M. Brown, Dennis Brown and the late Steven Hebert for their mentorship and support, and for inspiring their work on the renal CaSR.
Author information
Authors and Affiliations
Contributions
Both authors researched data for the article, provided a substantial contribution to discussions of the content, contributed equally to writing the article and to review and/or editing of the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Riccardi, D., Valenti, G. Localization and function of the renal calcium-sensing receptor. Nat Rev Nephrol 12, 414–425 (2016). https://doi.org/10.1038/nrneph.2016.59
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2016.59
This article is cited by
-
Ahnak is required to balance calcium ion homeostasis and smooth muscle development in the urinary system
Cell & Bioscience (2023)
-
Calcium sensing receptor stimulates breast cancer cell migration via the Gβγ-AKT-mTORC2 signaling pathway
Journal of Cell Communication and Signaling (2022)
-
Olive Leaf Extract (OLE) impaired vasopressin-induced aquaporin-2 trafficking through the activation of the calcium-sensing receptor
Scientific Reports (2021)
-
Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
Scientific Reports (2021)
-
The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases
Nature Reviews Endocrinology (2019)